| 臺大學術典藏 |
2022-09-15T03:00:13Z |
Validation of clinical frailty scale in Chinese translation
|
Chou Y.-C.; Tsou H.-H.; Chan D.-C.D.; Wen C.-J.; Lu F.-P.; Lin K.-P.; Wu M.-C.; YUNG-MING CHEN; Chen J.-H. |
| 臺大學術典藏 |
2022-08-19T00:20:50Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Cheng A.-L.; Chen P.-J.; Liu T.-W.; Chang C.-S.; Tien H.-F.; CHIUN HSU; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J. |
| 臺大學術典藏 |
2022-08-19T00:20:43Z |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang N.-J.; CHIUN HSU; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Huang S.-F.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:20:39Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
CHIUN HSU; Taiwan Cooperative Oncology Group; Liu T.-W.; Chen P.-J.; Cheng A.-L.; Lin J.; Yuan Q.; Xia N.; Yao M.; Lin S.-J.; Chen J.-H.; Chang C.-S.; Pei S.-N.; Tsou H.-H.; Yang H.-C. |
| 臺大學術典藏 |
2022-08-19T00:20:36Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Cheng A.-L.; CHIUN HSU; Taiwan Cooperative Oncology Group; Chen P.-J.; Tsui C.-W.; Wu H.-Y.; Hsu Y.-T.; Chuang M.-H.; Hsiung C.A.; Liu T.-W.; Yang H.-C.; Hsiao C.-F.; Tsou H.-H. |
| 臺大學術典藏 |
2022-05-05T05:15:32Z |
The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan
|
Tsou H.-H.; Cheng Y.-C.; Yuan H.-Y.; Hsu Y.-T.; Wu H.-Y.; Lee F.-J.; Hsiung C.A.; WEI J. CHEN; Sytwu H.-K.; Wu S.-I.; Shih S.-M.; Wen T.-H.; Kuo S.-C. |
| 臺大學術典藏 |
2022-05-05T05:15:30Z |
Nonpolio enterovirus activity during the COVID-19 Pandemic, Taiwan, 2020
|
Kuo S.-C.; Tsou H.-H.; Wu H.-Y.; Hsu Y.-T.; Lee F.-J.; Shih S.-M.; Hsiung C.A.; WEI J. CHEN |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 國立成功大學 |
2022 |
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study
|
Bai, L.-Y.;Li, C.-P.;Shan, Y.-S.;Chuang, S.-C.;Chen, J.-S.;Chiang, N.-J.;Chen, Y.-Y.;Tsou, H.-H.;Chuang, M.-H.;Chiu, Chiu C.-F.;Liu, T.-W.;Chen, L.-T. |
| 臺大學術典藏 |
2021-12-02T05:19:49Z |
Integrated care for geriatric frailty and sarcopenia: a randomized control trial
|
Chan D.-C.D.; Tsou H.-H.; CHIRN-BIN CHANG; Yang R.-S.; Tsauo J.-Y.; Chen C.-Y.; Hsiao C.-F.; Hsu Y.-T.; Chen C.-H.; Chang S.-F.; Hsiung C.A.; Kuo K.N. |
| 臺大學術典藏 |
2021-09-01T01:53:40Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:27Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-08-31T06:29:20Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-08-12T04:01:22Z |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang N.-J.; Chen M.-H.; YANG SHIH-HUNG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2021-08-10T03:53:00Z |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2021-07-12T02:44:25Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H; | HUNG-CHIH YANG; | Hsiao C.-F; | Hsiung C.A; | Liu T.-W; | Chuang M.-H; | Wu H.-Y; | Hsu Y.-T; | Tsui C.-W; | Chen P.-J; | Cheng A.-L; | Hsu C; | Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-03T03:34:10Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:33:36Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-03T03:33:29Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-05-31T02:57:13Z |
A pilot randomized controlled trial to improve geriatric frailty
|
Chan D.-C.D.; Tsou H.-H.; RONG-SEN YANG; Tsauo J.-Y.; Chen C.-Y.; Hsiung C.A.; Kuo K.N. |
| 臺大學術典藏 |
2021-05-31T02:57:09Z |
A 12-year ecological study of hip fracture rates among older Taiwanese adults
|
Chan D.-C.; Lee Y.-S.; Wu Y.-J.; Tsou H.-H.; Chen C.-T.; Hwang J.-S.; Tsai K.-S.; RONG-SEN YANG |
| 臺大學術典藏 |
2021-05-31T02:56:57Z |
Integrated care for geriatric frailty and sarcopenia: a randomized control trial
|
Chan D.-C.D.;Tsou H.-H.;Chang C.-B.;Rong-Sen Yang;Tsauo J.-Y.;Chen C.-Y.;Hsiao C.-F.;Hsu Y.-T.;Chen C.-H.;Chang S.-F.;Hsiung C.A.;Kuo K.N.; Chan D.-C.D.; Tsou H.-H.; Chang C.-B.; RONG-SEN YANG; Tsauo J.-Y.; Chen C.-Y.; Hsiao C.-F.; Hsu Y.-T.; Chen C.-H.; Chang S.-F.; Hsiung C.A.; Kuo K.N. |
| 臺大學術典藏 |
2021-04-20T08:30:31Z |
The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan
|
Tsou H.-H.; Cheng Y.-C.; Yuan H.-Y.; Hsu Y.-T.; Wu H.-Y.; Lee F.-J.; Hsiung C.A.; WEI J. CHEN; Sytwu H.-K.; Wu S.-I.; Shih S.-M.; Wen T.-H.; Kuo S.-C. |
| 臺大學術典藏 |
2021-04-20T08:30:29Z |
Nonpolio enterovirus activity during the COVID-19 Pandemic, Taiwan, 2020
|
Huang, Shao-Zu;Chuang, Yu-Chuan;Hung, Po-Chen;Chen, Chih-Yong;Chiang, Su-Yin;Kuen-Yuh Wu; Kuo S.-C.; Tsou H.-H.; Wu H.-Y.; Hsu Y.-T.; Lee F.-J.; Shih S.-M.; Hsiung C.A.; WEI J. CHEN |
| 臺大學術典藏 |
2021-03-10T08:55:48Z |
A 12-year ecological study of hip fracture rates among older Taiwanese adults
|
Chan D.-C.; Lee Y.-S.; Wu Y.-J.; Tsou H.-H.; Chen C.-T.; Hwang J.-S.; KEH-SUNG TSAI; Yang R.-S. |
